Filtered By:
Procedure: Heart Transplant

This page shows you your search results in order of date. This is page number 6.

Order by Relevance | Date

Total 211 results found since Jan 2013.

A Vigilante in Statistical Badlands
This study, for instance, attributes a patient’s waitlist/transplant outcome to the very last dialysis facility the patient was associated with.  In epidemiology speak, this means the causal inference authors are trying to draw between for-profit status and good transplant outcomes is subject to time-varying confounding. As an example, if one is seeking an association between testosterone levels and risk of a heart attack, using the last testosterone level available would be a poor way of doing this study because testosterone levels are known to vary over time. The same applies to dialysis facilities. Patients chan...
Source: The Health Care Blog - May 25, 2020 Category: Consumer Health News Authors: Christina Liu Tags: Medical Practice Physicians Eric Weinhandl JAMA medical research public health Public Policy public policy research Source Type: blogs

Adding Voice to Respiratory and Cardiovascular Disease Diagnosis: Interview with Prof. Elad Maor
The field of telehealth is growing thanks to the steady growth in supportive technology and the need for remote monitoring, assessment, diagnosis, and testing. Voice is unique to every individual due to people’s anatomical differences, which ma...
Source: Medgadget - April 29, 2020 Category: Medical Devices Authors: Rukmani Sridharan Tags: Cardiology Diagnostics Exclusive Public Health Source Type: blogs

Digital Twins and the Promise of Personalized Medicine
Can you guess the percentage of patients with Alzheimer’s on whom medication is ineffective? What about those with arthritis? Or cardiac arrhythmia? In fact, you don’t have to guess as the US Food and Drug Administration (FDA) already has the answers: 70%, 50% and 40% respectively. The percentage of patients for whom medications are ineffective range from 38-75% for varying conditions from depression to osteoporosis.  The main cause is because of the very genetic makeup of every individual. The latter is so different and their interaction so unique that therapies for the “average patient” might very well no...
Source: The Medical Futurist - March 19, 2020 Category: Information Technology Authors: Prans Tags: Future of Medicine Personalized Medicine digital health technology healthcare data digital twin technology design Source Type: blogs

The 7 Must-Haves For The Doctor Of the 21st Century
While Doctor Who is embracing change, casting two female leads in a row as the titular character following the series’ tradition of having male leads, real life doctors should take some cues from the fictional doctor when it comes to change. For ages, physicians have been relying on traditional methods when it comes to consulting patients and follow a rote template akin to the following: patients see the doctor who auscultates them with manual techniques, without forgetting the stethoscope, and will prescribe them some medication or lifestyle change. In specific cases, they will recommend a more detailed diagnostic metho...
Source: The Medical Futurist - March 5, 2020 Category: Information Technology Authors: Prans Tags: Future of Medicine Portable Diagnostics digital health smartphone healthcare systems digital stethoscope Source Type: blogs

Artificial Tissue Patches to Heal Damaged Hearts
Post myocardial infarction (heart attack), damaged heart tissue doesn’t tend to heal very well. Not only is the pumping action weakened due to muscle cells dying, but the electrical signaling through the heart can also be impeded. Scientist...
Source: Medgadget - February 14, 2020 Category: Medical Devices Authors: Medgadget Editors Tags: Cardiac Surgery Cardiology Materials Source Type: blogs

First AI-Guided Ultrasound Gets Green Light from FDA
Caption Health, a company based outside of San Francisco, CA, won the first authorization from the FDA for an ultrasound software that guides clinicians at capturing images of the heart. The Caption Guidance software should work with any number of ul...
Source: Medgadget - February 12, 2020 Category: Medical Devices Authors: Medgadget Editors Tags: Anesthesiology Cardiac Surgery Cardiology Critical Care Diagnostics Education Emergency Medicine Informatics Military Medicine Radiology Source Type: blogs

Biorobotic Hybrid Heart to Help Develop New Cardiac Implants
Prosthetic heart valves, ventricular assist devices, and other cardiac implants go through an extensive research and development process, followed by testing on animals before human trials. There is no machine that simulates the function of the heart...
Source: Medgadget - February 3, 2020 Category: Medical Devices Authors: Medgadget Editors Tags: Cardiac Surgery Cardiology Materials Source Type: blogs

Abbott ’s Tendyne First Transcatheter Mitral Valve to Win EU Clearance
Abbott just announced that it is the first company to receive European regulatory approval to introduce transcatheter mitral valve replacement procedures on the continent. The Tendyne Transcatheter Mitral Valve Implantation (TMVI) system is intended ...
Source: Medgadget - January 30, 2020 Category: Medical Devices Authors: Medgadget Editors Tags: Anesthesiology Cardiac Surgery Cardiology Radiology Source Type: blogs

Eko ’s AI-Powered Stethoscopes Detect AFib, Heart Murmurs
Eko, a maker of high-end digital stethoscopes, has just received the first FDA clearance for its devices to use AI algorithms to automatically detect atrial fibrillation (AFib) and heart murmurs. Using this capability, primary care physicians, who ar...
Source: Medgadget - January 28, 2020 Category: Medical Devices Authors: Medgadget Editors Tags: Anesthesiology Cardiology Pediatrics Source Type: blogs

HFrecEF – HF with recovered EF
HFrecEF – HF with recovered EF Classification of heart failure is ever changing. We had heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF). Then came heart failure with mid range ejection fraction (HFmrEF) with ejection fraction between 40 and 50%. Yet another entity is heart failure with recovered ejection fraction (HFrecEF) [1]. Over half of patients with history of heart failure and left ventricular ejection fraction above 50% have HFrecEF. It has a better prognosis than HFrEF and HFpEF, but is likely to be mistook for the latter. They are less likely to...
Source: Cardiophile MD - December 28, 2019 Category: Cardiology Authors: Prof. Dr. Johnson Francis Tags: Cardiology Source Type: blogs

DOACs now recommended over warfarin to prevent blood clots in people with atrial fibrillation
For decades, warfarin (Coumadin) was the standard anticoagulant medication used to prevent blood clots, which can lead to stroke, in people with atrial fibrillation (afib). Direct oral anticoagulants (DOACs), sometimes called novel oral anticoagulants (NOACs), are a new type of anticoagulant medication that came on the market in 2010. In 2019, the American Heart Association/American College of Cardiology/Heart Rhythm Society (AHA/ACC/HRS) updated their afib guidelines to strongly recommend using DOACs over warfarin in people with afib. Warfarin is effective, but has downsides Afib is a condition in which the upper chambers...
Source: Harvard Health Blog - December 16, 2019 Category: Consumer Health News Authors: Peter Zimetbaum, MD Tags: Drugs and Supplements Heart Health Source Type: blogs

MELD and MELD-XI scores
Model for End-Stage Liver Disease (MELD) score is a logarithmic function of creatinine, total bilirubin and International Hospitalized Ratio (INR): MELD = 9.57(logeCreatinine) + 3.78(logeBilirubin) + 11.21(logeINR) + 6.43. MELD score was originally developed to assess prognosis in patients undergoing transjugular intrahepatic portosystemic shunts (TIPS) for cirrhosis liver [1]. Later MELD score has been used in cardiovascular conditions like patients undergoing left ventricular assist device (LVAD) placement to operative transfusion requirements, morbidity, and mortality [2]. An important limitation for using MELD sc...
Source: Cardiophile MD - December 15, 2019 Category: Cardiology Authors: Prof. Dr. Johnson Francis Tags: Cardiology Source Type: blogs

Canon Unveils Aquilion ONE / PRISM Edition Spectral CT Scanner
At the RSNA 2019 conference in Chicago, Canon Medical showed off its brand new Aquilion ONE / PRISM Edition spectral CT scanner, a system that takes advantage of artificial intelligence technologies. The device relies on Canon’s Advanced int...
Source: Medgadget - December 6, 2019 Category: Medical Devices Authors: Medgadget Editors Tags: Anesthesiology Cardiology Critical Care Diagnostics Emergency Medicine Neurology Ob/Gyn Oncology Radiology Source Type: blogs

Silicon Chips as Artificial Neurons
Researchers at the University of Bath in the UK have developed low-power silicon chips that mimic the electrical activity of neurons. This breakthrough could enable the small chips to function as artificial neurons in numerous implants and medical de...
Source: Medgadget - December 5, 2019 Category: Medical Devices Authors: Conn Hastings Tags: Cardiology Neurology Neurosurgery News Source Type: blogs

20 Medical Technology Advances: Medicine in the Future – Part II.
Nanorobots swimming in blood vessels, in silico clinical trials instead of experimenting with drugs on animals and people, remote brain surgeries with the help of 5G networks – the second part of our shortlist on some astonishing ideas and innovations that could give us a glimpse into the future of medicine is ready for you to digest. Here, we’re going beyond the first part with medical tricorders, the CRISPR/Cas-9 gene-editing method, and other futuristic medical technologies to watch for. 11) In silico clinical trials against testing drugs on animals As technologies transform every aspect of healthcare,...
Source: The Medical Futurist - October 23, 2019 Category: Information Technology Authors: berci.mesko Tags: Artificial Intelligence E-Patients Future of Medicine Future of Pharma Genomics Health Sensors & Trackers 3d printing AI bioprinting blockchain clinical trials CRISPR digital digital health drug development genetics Innovat Source Type: blogs